A combination pill is a type of birth control pill that contains two hormones: a synthetic estrogen and a progestin. It’s the most commonly used form of oral contraception, and when taken perfectly, it’s 99.7% effective at preventing pregnancy. In typical real-world use, that number drops to about 91%, mostly because of missed pills or late starts.
How It Prevents Pregnancy
The combination pill works through two main actions. First, the hormones stop your ovaries from releasing an egg each month. No egg means nothing for sperm to fertilize. Second, the progestin thickens the mucus at the opening of the cervix, creating a barrier that makes it much harder for sperm to reach the uterus at all.
What’s Actually in the Pill
Every combination pill pairs an estrogen with a progestin, but not all pills use the same ones. The most common estrogen has been ethinylestradiol, used for decades because the body absorbs it efficiently. Newer formulations use estradiol (the same estrogen your body makes naturally) or estetrol, a plant-derived estrogen approved since 2021 that appears to have less impact on liver function, blood clotting, and breast tissue compared to older estrogens.
The progestin component varies more widely, and the type chosen often determines what additional benefits a pill offers. Older progestins like levonorgestrel and norethisterone have been in use since the 1960s and have long safety track records. Newer options like desogestrel and gestodene bind more precisely to progesterone receptors. Drospirenone has a mild diuretic effect and can help with severe premenstrual symptoms. Cyproterone has anti-androgen properties, making it particularly useful for women dealing with severe acne.
Dosing Schedules and Pack Types
The classic combination pill pack contains 21 active hormone pills followed by 7 placebo (sugar) pills, during which you get a withdrawal bleed that resembles a period. A newer common format uses 24 active pills and 4 placebos, which shortens the hormone-free window and can mean lighter, shorter bleeding.
Extended-cycle packs stretch things further. Some contain 84 active pills followed by 7 placebos, meaning you only have a withdrawal bleed every three months. Others are designed for continuous use with no planned breaks at all. These extended regimens are just as effective at preventing pregnancy as the traditional 21/7 schedule.
Monophasic vs. Multiphasic
In a monophasic pill, every active pill in the pack delivers the same dose of hormones. Triphasic pills change the hormone levels across three phases over the month, roughly mimicking the natural rise and fall of hormones during a menstrual cycle. There are also biphasic (two phases) and quadriphasic (four phases) options. The quadriphasic pill pairs estradiol valerate with dienogest and is specifically designed to reduce heavy menstrual bleeding. In practice, monophasic and multiphasic pills are similarly effective at preventing pregnancy.
Benefits Beyond Birth Control
Many people take combination pills for reasons that have nothing to do with preventing pregnancy. Pills containing anti-androgenic progestins are effective treatments for acne, excess facial or body hair, and oily skin. For women with polycystic ovary syndrome (PCOS), the pill can normalize ovarian structure and size while managing symptoms like irregular periods and hormonal acne.
Endometriosis pain responds well to combination pills. They’re considered comparable to more expensive hormone treatments but come with fewer side effects and can be used for longer stretches. The same goes for adenomyosis, a related condition where uterine tissue grows into the muscular wall of the uterus, causing painful, heavy periods.
One of the most striking long-term benefits is cancer risk reduction. A 2025 meta-analysis found that combination pill users had roughly 40% lower odds of developing endometrial cancer compared to nonusers. Women who used the pill for 10 years or more saw the greatest protection, with up to a 69% reduction in risk. Ovarian cancer risk also drops with pill use, and the protective effect persists for years after stopping.
Who Should Avoid the Combination Pill
The estrogen component is what creates most of the safety concerns. Women who experience migraines with aura (visual disturbances, tingling, or other sensory warning signs before the headache) should not take combination pills because the estrogen increases the risk of stroke in this group. The same applies to women over 35 who smoke, as the combination of estrogen, nicotine, and age significantly raises the chance of blood clots and cardiovascular problems.
Other situations where the combination pill is typically not recommended include a history of blood clots, certain heart conditions, uncontrolled high blood pressure, and some types of liver disease. In these cases, a progestin-only pill or non-hormonal method is a safer choice.
What to Do If You Miss a Pill
Missing a single pill (up to 48 hours late) is relatively simple to manage. Take the missed pill as soon as you remember, then take the next one at your usual time, even if that means swallowing two pills in one day. No backup contraception is needed.
Missing two or more pills in a row is more serious. Take the most recent missed pill right away and discard any others you skipped. You’ll need to use condoms or avoid intercourse for the next 7 days while the hormones rebuild in your system. If those missed pills fell in the last week of active pills in your pack, skip the placebo pills entirely and start a new pack immediately. If you missed pills during the first week and had unprotected sex in the previous five days, emergency contraception is worth considering.
Newer Formulations
The newest combination pill on the market pairs estetrol with drospirenone, approved under brand names including Nextstellis and Drovelis. Estetrol interacts with estrogen receptors differently than older estrogens. It activates them inside the cell nucleus but blocks their activity at the cell membrane, which translates to less stimulation of liver proteins involved in blood clotting. In clinical trials, this pill had a negligible effect on clotting markers compared to pills containing ethinylestradiol. Users also saw minimal changes in cholesterol, blood sugar, and triglycerides.
Bleeding predictability is another selling point. By the second month of use, 89% of women on estetrol-drospirenone had regular, scheduled bleeding, and that number held steady at 90% by month 12. Unscheduled spotting dropped to 18% or less after the first five cycles.